LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE
Clinical trials for LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE trials appear
Sign up with your email to follow new studies for LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young leukemia patients: experimental drug combo targets resistant cancer
Disease control Recruiting nowThis study tests a new drug called asciminib, given with chemotherapy and later with another drug (blinatumomab), in children, teens, and young adults up to age 30 who have a type of leukemia (Ph+ or Ph-like ALL) that has come back or not responded to treatment. The goal is to fi…
Matched conditions: LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug combo aims to beat leukemia in phase 3 trial
Disease control Recruiting nowThis phase 3 study tests whether adding the experimental drug olverembatinib to standard chemotherapy works better than the usual targeted therapy (a TKI) plus chemotherapy for people newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Th…
Matched conditions: LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE
Phase: PHASE3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC